These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34592628)
1. Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone. Oakes M; Arastu A; Kato C; Somers J; Holly HD; Elstrott BK; Dy GW; Kohs TCL; Patel RR; McCarty OJT; DeLoughery TG; Milano C; Raghunathan V; Shatzel JJ Thromb Res; 2021 Nov; 207():96-98. PubMed ID: 34592628 [TBL] [Abstract][Full Text] [Related]
2. Erythrocytosis in Gender-Affirming Care With Testosterone. Porat AT; Ellwood M; Rodina M; Dianat S Ann Fam Med; 2023; 21(5):403-407. PubMed ID: 37748907 [TBL] [Abstract][Full Text] [Related]
3. Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy. Krishnamurthy N; Slack DJ; Kyweluk M; Cullen O; Kirkley J; Safer JD J Clin Endocrinol Metab; 2024 Apr; 109(5):1285-1290. PubMed ID: 38011684 [TBL] [Abstract][Full Text] [Related]
4. Effect of testosterone formulations on hematocrit in transgender individuals: A systematic review. Okano SHP; Braga GC; Cantelli DAL; Filho LASP; Brito LGO; Lara LADS Andrology; 2024 Jul; ():. PubMed ID: 39011565 [TBL] [Abstract][Full Text] [Related]
5. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years. Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M J Clin Endocrinol Metab; 2021 May; 106(6):1710-1717. PubMed ID: 33599731 [TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. Defreyne J; Vantomme B; Van Caenegem E; Wierckx K; De Blok CJM; Klaver M; Nota NM; Van Dijk D; Wiepjes CM; Den Heijer M; T'Sjoen G Andrology; 2018 May; 6(3):446-454. PubMed ID: 29602229 [TBL] [Abstract][Full Text] [Related]
10. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY. Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729 [TBL] [Abstract][Full Text] [Related]
11. Testosterone Pellet Use in Transgender Men. Cheng K; Skolnick A Transgend Health; 2023 Dec; 8(6):494-499. PubMed ID: 38130978 [TBL] [Abstract][Full Text] [Related]
12. High-oxygen-affinity hemoglobinopathy-associated erythrocytosis: Clinical outcomes and impact of therapy in 41 cases. Gangat N; Oliveira JL; Hoyer JD; Patnaik MM; Pardanani A; Tefferi A Am J Hematol; 2021 Dec; 96(12):1647-1654. PubMed ID: 34633117 [TBL] [Abstract][Full Text] [Related]
13. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male. Jones SD; Dukovac T; Sangkum P; Yafi FA; Hellstrom WJ Sex Med Rev; 2015 Apr; 3(2):101-112. PubMed ID: 27784544 [TBL] [Abstract][Full Text] [Related]
14. Affirming Hormone Treatment for a Transgender Adolescent After a Venous Thromboembolic Event. Penney SW; Jung JH; Ballantyne AJ; Parekh DS; Klein DA; Viola SA J Pediatr Hematol Oncol; 2022 Jul; 44(5):e892-e895. PubMed ID: 35293883 [TBL] [Abstract][Full Text] [Related]
15. Effects of gender affirming hormone therapy with testosterone on coagulation and hematological parameters in transgender people assigned female at birth: A systematic review and meta-analysis. Tienforti D; Pastori D; Barbonetti A Thromb Res; 2024 Apr; 236():170-178. PubMed ID: 38457996 [TBL] [Abstract][Full Text] [Related]
16. Early Access to Testosterone Therapy in Transgender and Gender-Diverse Adults Seeking Masculinization: A Randomized Clinical Trial. Nolan BJ; Zwickl S; Locke P; Zajac JD; Cheung AS JAMA Netw Open; 2023 Sep; 6(9):e2331919. PubMed ID: 37676662 [TBL] [Abstract][Full Text] [Related]
17. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review. Velho I; Fighera TM; Ziegelmann PK; Spritzer PM Andrology; 2017 Sep; 5(5):881-888. PubMed ID: 28709177 [TBL] [Abstract][Full Text] [Related]
18. Retrospective review of changes in testosterone dosing and physiologic parameters in transgender and gender-diverse individuals following hysterectomy with and without oophorectomy. Grimstad FW; Fraiman E; Garborcauskas G; Ferrando CA J Sex Med; 2023 Apr; 20(5):690-698. PubMed ID: 36987750 [TBL] [Abstract][Full Text] [Related]
19. Effects of testosterone treatment on transgender males: A single-institution study. Korpaisarn S; Chiewchalermsri D; Arunakul J; Chinthakanan O; Poomthavorn P; Sriphrapradang C SAGE Open Med; 2021; 9():20503121211051546. PubMed ID: 34659767 [TBL] [Abstract][Full Text] [Related]
20. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review. Spanos C; Bretherton I; Zajac JD; Cheung AS World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]